Publicaciones (25) Publicaciones de RAQUEL DÍAZ SIMÓN

2024

  1. Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis(Front. Immunol., (2024), 15, (1443096), 10.3389/fimmu.2024.1443096)

    Frontiers in Immunology

  2. Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

    Frontiers in Immunology, Vol. 15

2023

  1. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

  2. Nosocomial COVID-19: A Nationwide Spanish Study

    Gerontology, Vol. 69, Núm. 6, pp. 671-683

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  3. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

    Frontiers in Medicine, Vol. 9

  4. Sporadic, non-functional, gastrin-producing duodenal neuroendocrine tumors: A retrospective study of an infrequent disease

    Journal of Digestive Diseases, Vol. 23, Núm. 8-9, pp. 455-461

  5. The early use of sepsis scores to predict respiratory failure and mortality in non-ICU patients with COVID-19

    Revista Clinica Espanola, Vol. 222, Núm. 5, pp. 293-298

2021

  1. Anti‐phospholipid antibodies and covid‐19 thrombosis: A co‐star, not a supporting actor

    Biomedicines, Vol. 9, Núm. 8

  2. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

  3. Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome

    Frontiers in Immunology, Vol. 12

  4. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry

    Journal of General Internal Medicine, Vol. 36, Núm. 10, pp. 3080-3087

  5. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416

  6. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 6, pp. 1209-1216

  7. Presence of extra-criteria antiphospholipid antibodies is an independent risk factor for ischemic stroke

    Frontiers in Cardiovascular Medicine, Vol. 8

  8. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2020

  1. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

    Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 8, Núm. 3, pp. 353-359.e1

  2. Patients with a high cardiovascular risk and atrial fibrillation: the role of rivaroxaban

    Revista Espanola de Cardiologia Suplementos, Vol. 20, pp. 30-38

  3. Quality of Life After a Venous Thrombosis in Elderly Patients: Results From a Prospective Spanish Cohort

    Archivos de Bronconeumologia, Vol. 56, Núm. 3, pp. 187-188